Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies

Identification of SHV-Type and CTX-M-12 Extended-Spectrum β-Lactamases (ESBLs) in MultiresistantEnterobacteriaceaefrom Colombian Caribbean Hospitals

(2014) P. Espinal et al.   JOURNAL OF CHEMOTHERAPY

Epidemiology and Risk Factors for Isolation of Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamase in a Large U.S. Medical Center

(2013) Kayoko Hayakawa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular epidemiology of Escherichia coli O25b-ST131 isolates causing community-acquired UTIs in Mexico

(2013) Fernando Reyna-Flores et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Characterization of Enterobacteriaceae Isolates Obtained from a Tertiary Care Hospital in Mexico, Which Produces Extended-Spectrum β-Lactamase

(2013) Rayo Morfín-Otero et al.   Microbial Drug Resistance

Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies

(2012) B. J. Liss et al.   INFECTION

Molecular Analysis and Risk Factors for Escherichia coli Producing Extended-Spectrum β-Lactamase Bloodstream Infection in Hematological Malignancies

(2012) Patricia Cornejo-Juárez et al.   PLoS One

Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis

(2012) Yaron Ilan   WORLD JOURNAL OF GASTROENTEROLOGY

Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy

(2011) Cheol-In Kang et al.   ANNALS OF HEMATOLOGY

Association of the Extended-Spectrum  -Lactamase Gene blaTLA-1 with a Novel ISCR Element, ISCR20

(2010) B. Bercot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical and economic outcomes associated with community-acquired intra-abdominal infections caused by extended spectrum beta-lactamase (ESBL) producing bacteria in China

(2010) Bijie Hu et al.   CURRENT MEDICAL RESEARCH AND OPINION

Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies

(2010) M. Arnan et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases

(2010) U.-I. Wu et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Febrile Neutropenia

(2009) Michael Ellis   Annals of the New York Academy of Sciences

A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients

(2009) Ronen Ben‐Ami et al.   CLINICAL INFECTIOUS DISEASES

Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains

(2009) O. Clermont et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Extended-spectrum β-lactamase-producing organisms

(2009) M.E. Falagas et al.   JOURNAL OF HOSPITAL INFECTION

Carbapenem-Resistant Enterobacteriaceae

(2008)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup

(2008) Olivier Clermont et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY